During the past decade, Sampson Regional Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sampson Regional Medical Center" are "Advanced Cancer" (1 trials) and "Metastatic Pancreatic Ductal Adenocarcinoma" (1 trials). Many other conditions were trialed in "Sampson Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Sampson Regional Medical Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (1 trials), "CMP-001" (1 trials), "Gemcitabine" (1 trials), "Nab-paclitaxel" (1 trials) and "PD 0360324" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sampson Regional Medical Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sampson Regional Medical Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Sampson Regional Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sampson Regional Medical Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".